The Antibody Drug Conjugate (ADC) IMGN779 is Highly Active In Vitro and In Vivo Against Acute Myeloid Leukemia (AML) with FLT3-1TD Mutations
IMMUNOGEN IS NOW PART OF ABBVIE
Together we will be working to make a remarkable impact for cancer patients and their communities of care, raising standards of care and advancing a dynamic oncology pipeline.